Lanthanide-doped CaF2 and SrF2 nanoparticles for biomedical applications: in vivo and in vitro experimental studies by Portioli, Corinne et al.
IJAE 
Vo l .  120 ,  n .  1  (Supp lem ent) :  185,  2015
© 2015 Firenze University Press 
ht tp://www.fupress .com/ijae
ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY
Lanthanide-doped CaF2 and SrF2 nanoparticles 
for biomedical applications: in vivo and in vitro 
experimental studies 
Corinne Portioli1, Marco Pedroni2, Donatella Benati1, Stefano Dusi3, Marta Donini3, Raffaella 
Mariotti1, Roberta Bonafede1, Luigi Perbellini4, Marzia Cerpelloni4, Adolfo Speghini2, Marina 
Bentivoglio1
1 Dipartimento di Scienze Neurologiche e del Movimento, Università di Verona, Verona, Italy - 2 Dipartimento 
di Biotecnologie, Università di Verona, Verona, Italy - 3 Dipartimento di Patologia, Università di Verona, Verona, 
Italy - 4 Dipartimento di Salute Pubblica e di Comunità, Università di Verona, Verona, Italy
Among the wide range of nanoparticles (NPs) studied for diagnostic and thera-
peutic applications lanthanide-doped nanosystems have raised special interest 
[1]. Their very small dimension (10 nm) and upconversion emission property have 
increased the range of their applications from contrast agent probes in bioimaging to 
drug delivery systems [2,3]. Here, the cytotoxicity of rare earth (Yb and Er)-doped 
CaF2 and SrF2 NPs has been investigated both in vitro and in vivo. In vitro studies 
have been conducted in a motoneuron cell line as model of neuronal interaction, and 
in a line of human dendritic cells which play a key role in the immune response. In 
the motoneuron cell line, a weak response was observed at early time points while 
the cell viability showed an increment, except for the highest concentration of lan-
thanide-doped NPs. The levels of cytokines released from human dendritic cells 
were low and dose-dependent. The NP biodistribution was investigated after a sin-
gle peripheral administration in mice. Aggregates of NPs were shown, with differ-
ent techniques, mostly in peripheral organs (spleen and liver) after one day. A limited 
penetration of both CaF2 and SrF2 NPs was seen in the brain parenchyma, associated 
with a mild astrocytic activation. Since the present in vitro findings indicate that lan-
thanide-doped NPs are safe, and the in vivo data show that they can enter the brain 
parenchyma crossing the blood-brain barrier, these NPs may represent promising 
tools for diagnostic and therapeutical applications.
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